![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Realm Therapeutics PLC | NASDAQ:RLM | NASDAQ | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.50 | 2.20 | 3.50 | 0 | 01:00:00 |
|
REALM THERAPEUTICS PLC
|
|
|
|
|
Date: August 1, 2019
|
By:
|
/s/ Marella Thorell
|
|
|
Name: Marella Thorell
|
|
|
Title: Chief Financial Officer and Chief Operating Officer
|
*
|
On July 31, 2019, pursuant to the Implementation Agreement, dated as of May 15, 2019, by and between Realm Therapeutics plc (the “Company”) and Essa Pharma Inc., a company incorporated in British Columbia, Canada (the “Purchaser”), the Purchaser acquired the entire issued and to be issued share capital of the Company.
|
1 Year Realm Therapeutics Chart |
1 Month Realm Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions